In honor of Breast Cancer Awareness Month, Raising Cane’s will donate $100K of today’s net proceeds to the University of Pennsylvania’s Abramson Cancer Center, a world leader in cancer research, patient care and education. The brand encourages Customers to stop by their local Raising Cane’s today to help support breast cancer research and awareness.
Raising Cane’s will make its donation in the name of 34-year-old breast cancer survivor, Kate Korson. The Philadelphia native, who was diagnosed with stage III triple-negative breast cancer just one week before her 34th birthday, began receiving treatment at the Abramson Cancer Center in January, the same treatment facility her mother was treated 17 years prior for rectal cancer.
Kate enrolled in the I-SPY2 clinical trial – a faster, less toxic treatment regimen that allowed her to receive a new type of therapy and proceed to surgery after only four infusions. The trial was overseen by Penn Medicine’s team of female physicians and nearly eliminated her cancer entirely. Kate now begins preventative care, which includes several weeks of radiation and chemotherapy.
“The Abramson Cancer Center is doing great work in preventative care, research and patient care for cancers of all types,” said Raising Cane’s founder Todd Graves. “In recognition of Breast Cancer Awareness Month, we’re proud to celebrate and honor those currently battling breast cancer as well as survivors like Kate by supporting UPENN’s ongoing efforts in saving the lives of those fighting against breast cancer.”
To support Raising Cane’s donation efforts, Customers are encouraged to visit Raising Cane’s today during regular operational hours. The donation will be automatically applied to all orders and Customers do not need to mention the donation. To find a location nearest you, please visit https://www.raisingcanes.com/locations/.
DETAILS
WHAT: Raising Cane’s to donate $100K of today’s net proceeds to UPENN’s Abramson Cancer Center
WHEN: All day today (Monday, October 2)
WHERE: All Raising Cane’s U.S. Restaurants
ABOUT PENN MEDICINE’S ABRAMSON CANCER CENTER:
Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care and education. Our preeminent position is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 51 such centers in the United States. At the Abramson Cancer Center, we are dedicated to innovative and compassionate cancer care. Our clinical program, comprised of a dedicated staff of physicians, nurse practitioners, nurses, social workers, physical therapists, nutritionists and patient care coordinators, currently sees 305,248 outpatient visits and more than 10,230 discharges, and provides more than 81,471 chemotherapy and 66,110 radiation treatments. Not only are we dedicated to providing state-of-the-art care, the latest forms of cancer prevention, diagnoses and treatments are available to our patients through clinical themes developed in the relentless pursuit to eliminate the pain and suffering from cancer, with more than 9,069 participants in nearly 600 clinical trials. In addition, the Abramson Cancer Center is home to the 400+ basic, translational and clinical scientists who relentlessly work to determine the pathogenesis of cancer. Together, our faculty is committed to improving the prevention, diagnosis and treatment of cancer
